Tradestie Institutional Equity Comparison Engine

BDRX vs SRTM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BDRX Overall Edge

BDRX Captures Institutional Edge (2โ€“0 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, BDRX trades at N/M Forward P/E with 0.0% operating margin (-64.1% YoY revenue) versus SRTM at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, BDRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SRTM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
BDRX N/M vs SRTM N/M Fwd P/E
Growth & Margin Winner BDRX
Op Margin 0.0% vs N/A ยท YoY -64.1% vs N/A
Momentum & Technical Winner BDRX
1Y -51.4% vs -86.8% ยท 52W Pos 18% vs 2%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
BDRX NASDAQ
Biodexa Pharmaceuticals plc American Depositary Shs
Pharmaceutical Preparations
$1.88
-6.02% 1D
Market Cap $1.0M
1M Return +352.9%
1Y Return -51.42%
Forward P/E N/M
Unified AI Score
36.0 / 100 SELL
Tech 15.0 Fund 36.0 Flow 50.0 Mom 50.0
SRTM US Equity
SRTM
Institutional Equity
$0.08
-14.59% 1D
Market Cap N/A
1M Return -80.4%
1Y Return -86.83%
Forward P/E N/M
Unified AI Score
47.6 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BDRX -51.42% SRTM -86.83% Spread: +466.86 pp (BDRX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BDRX TTM Op. Margin: 0.0% SRTM TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BDRX vs SRTM. Trailing 12-month operating profitability (BDRX 0.0% vs SRTM N/A) and valuation multiples (BDRX N/M vs SRTM N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BDRX (6) vs SRTM (2)
Institutional Metric BDRX SRTM Criterion Row Winner
Market Capitalization Scale $1.0M N/A Larger Scale BDRX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -64.1% N/A Higher Growth BDRX
Operating Margin (TTM) Profitability 0.0% N/A Higher Margin BDRX
Net Profit Margin Profitability 0.0% N/A Higher Margin BDRX
Return on Equity (ROE) Capital Efficiency -42.0% N/A Higher ROE BDRX
52-Week Range Position Momentum 18% ($0โ€“$9) 2% ($0โ€“$1) Stronger Trend BDRX
Beta / 30D Volatility Risk Regime 5.62ฮฒ ยท 2621% Vol N/A Lower Realized Risk SRTM
Unified Institutional Score Composite Signal 36.0 / 100 (SELL) 47.6 / 100 (HOLD) Higher Composite SRTM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BDRX vs SRTM Buy Guide
BDRX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BDRX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SRTM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SRTM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BDRX nor SRTM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.